Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Alvarez-Mon

Showing results (21-30 of 149) with videos related to

Pageof 15
Sort By:
Stroke|August 1, 1990
Plasmapheresis in heparin-induced thrombocytopenia and thrombosisL Manzano, M Yebra, J A Vargas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1987
Inhibition of human natural killer (NK) activity by calcium channel modulators and a calmodulin antagonistJ J Solovera, M Alvarez-Mon, J Casas, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|January 1, 1992
[Anaphylaxis and hepatomegaly in a 22-year-old patient]R Martínez-Fernández, A Arranz, L Manzano, et al.
Science (New York, N.Y.)|November 20, 1987
Lymphotoxin is an important T cell-derived growth factor for human B cellsJ H Kehrl, M Alvarez-Mon, G A Delsing, et al.
The American Journal of Physiology|March 10, 1999
Factors mediating the hemodynamic effects of tumor necrosis factor-alpha in portal hypertensive ratsJ Muñoz, A Albillos, M Pérez-Páramo, et al.
Anti-Cancer Drugs|May 1, 1992
Analysis of the effect of intravesical treatment with interferon-alpha 2b on the clinical evolution and on the in vivo function of T lymphocytes and natural killer cells in patients with superficial bladder tumorsJ Carballido, L M Moltó, C Olivier, et al.
Revista Espanola De Enfermedades Digestivas|September 19, 1998
[Hepatitis B virus and the inflammatory/immunologic response (II): a new opportunity for the treatment of chronic hepatitis B and a suggestion for the treatment of other persistent viral diseases]V G Villarrubia, J M Herrerías, M Alvarez-Mon, et al.
Revista Clinica Espanola|May 1, 1992
[Marchiafava-Bignami disease with a favorable clinical evolution]R Martínez-Fernández, L Manzano, F Cabrera, et al.
International Journal of Immunopharmacology|November 1, 1992
Interleukin 2 and interferon alpha modulation of the lymphocyte non-major histocompatibility-restricted lytic activity in glioblastoma patientsP Lapeña, C Isasi, L Moltó, et al.
British Journal of Haematology|December 1, 1991
Increased percentage of activated T lymphocytes in B cell lymphocytic leukaemia (B-CLL) patientsJ Garcia-Suarez, A Prieto, E Reyes, et al.
Pageof 15

Showing results (21-30 of 149) with videos related to

Sort By:
Pageof 15
Stroke|August 1, 1990
Plasmapheresis in heparin-induced thrombocytopenia and thrombosisL Manzano, M Yebra, J A Vargas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1987
Inhibition of human natural killer (NK) activity by calcium channel modulators and a calmodulin antagonistJ J Solovera, M Alvarez-Mon, J Casas, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|January 1, 1992
[Anaphylaxis and hepatomegaly in a 22-year-old patient]R Martínez-Fernández, A Arranz, L Manzano, et al.
Science (New York, N.Y.)|November 20, 1987
Lymphotoxin is an important T cell-derived growth factor for human B cellsJ H Kehrl, M Alvarez-Mon, G A Delsing, et al.
The American Journal of Physiology|March 10, 1999
Factors mediating the hemodynamic effects of tumor necrosis factor-alpha in portal hypertensive ratsJ Muñoz, A Albillos, M Pérez-Páramo, et al.
Anti-Cancer Drugs|May 1, 1992
Analysis of the effect of intravesical treatment with interferon-alpha 2b on the clinical evolution and on the in vivo function of T lymphocytes and natural killer cells in patients with superficial bladder tumorsJ Carballido, L M Moltó, C Olivier, et al.
Revista Espanola De Enfermedades Digestivas|September 19, 1998
[Hepatitis B virus and the inflammatory/immunologic response (II): a new opportunity for the treatment of chronic hepatitis B and a suggestion for the treatment of other persistent viral diseases]V G Villarrubia, J M Herrerías, M Alvarez-Mon, et al.
Revista Clinica Espanola|May 1, 1992
[Marchiafava-Bignami disease with a favorable clinical evolution]R Martínez-Fernández, L Manzano, F Cabrera, et al.
International Journal of Immunopharmacology|November 1, 1992
Interleukin 2 and interferon alpha modulation of the lymphocyte non-major histocompatibility-restricted lytic activity in glioblastoma patientsP Lapeña, C Isasi, L Moltó, et al.
British Journal of Haematology|December 1, 1991
Increased percentage of activated T lymphocytes in B cell lymphocytic leukaemia (B-CLL) patientsJ Garcia-Suarez, A Prieto, E Reyes, et al.
Pageof 15